Showing results (2261-2270 of 6,794) with videos related to

Sort By:
Pageof 680
Clinical Therapeutics|July 7, 2001
A population pharmacokinetic model that describes multiple peaks due to enterohepatic recirculation of ezetimibeF Ezzet, G Krishna, D B Wexler, et al.
Clinical Therapeutics|July 7, 2001
A comparison of the skin permeation of three topical 0.5% fluorouracil formulations with that of a 5% formulationS Levy, K Furst, W Chern
Clinical Therapeutics|July 7, 2001
Efficacy of single-dose intravenous dolasetron versus ondansetron in the prevention of postoperative nausea and vomitingJ B Walker
Clinical Therapeutics|July 7, 2001
Responsiveness of the Smoking Cessation Quality of Life (SCQoL) questionnaireJ W Shaw, S J Coons, S A Foster, et al.
Clinical Therapeutics|September 18, 2001
Losartan versus valsartan in the treatment of patients with mild to moderate essential hypertension: data from a multicenter, randomized, double-blind, 12-week trialW J Elliott, D A Calhoun, P T DeLucca, et al.
Clinical Therapeutics|September 18, 2001
Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase II studiesH E Bays, P B Moore, M A Drehobl, et al.
Clinical Therapeutics|September 18, 2001
Pharmacokinetics and pharmacodynamics of aztreonam and tobramycin in hospitalized patientsP F Smith, C H Ballow, B M Booker, et al.
Clinical Therapeutics|January 30, 2002
A comparison of the efficacy and tolerability of brimonidine and latanoprost in adults with open-angle glaucoma or ocular hypertension: a three-month, multicenter, randomized, double-masked, parallel-group trialH B DuBiner, M Mroz, A M Shapiro, et al.
Clinical Therapeutics|January 30, 2002
Cost-Effectiveness of tolterodine for patients with urge incontinence who discontinue initial therapy with oxybutynin: a Canadian perspectiveB J O'Brien, R Goeree, L Bernard, et al.
Clinical Therapeutics|January 29, 2021
Meta-analysis of the Efficacy and Tolerability of Immune Checkpoint Inhibitors Combined With Chemotherapy in First-line Treatment of Small Cell Lung CancerJiao Wu, Aifen Zhang, Lu Li, et al.
Pageof 680